SciRepID - Management Thalassemia in Indonesia : A Literature Review

📅 14 December 2024
DOI: 10.62951/ijhm.v2i1.214

Management Thalassemia in Indonesia : A Literature Review

International Journal of Health and Medicine
Asosiasi Riset Ilmu Kesehatan Indonesia (ARIKESI)

📄 Abstract

Thalassemia is a disease classified in the group of hereditary hemolytic anemia caused by the failure of the formation of one of the four amino acid chains forming Hb, causing incomplete Hb formation. Thalassemia carriers account for 7% of the world's population.  At present, the cornerstone of treatment for β-TM in Indonesia remains supportive, including blood transfusions and iron chelation therapy. With a comprehensive discussion about thalassemia in Indonesia, it is hoped that the diagnosis and treatment of thalassemia will be more optimal and effective in future research.

🔖 Keywords

#Thalassemia; Management; Treatment; Indonesia

ℹ️ Informasi Publikasi

Tanggal Publikasi
14 December 2024
Volume / Nomor / Tahun
Volume 2, Nomor 1, Tahun 2024

📝 HOW TO CITE

Friska Kamila Nabilasefanty; Pradana Zaky Romadhon, "Management Thalassemia in Indonesia : A Literature Review," International Journal of Health and Medicine, vol. 2, no. 1, Dec. 2024.

ACM
ACS
APA
ABNT
Chicago
Harvard
IEEE
MLA
Turabian
Vancouver

🔗 Artikel Terkait dari Jurnal yang Sama

📊 Statistik Sitasi Jurnal

Tren Sitasi per Tahun